Avalo Therapeutics Inc

AVTX NASDAQ Santé & Biotech États-Unis US05338F2074
14.70 $
4.55 %

Avalo Therapeutics Inc développe des traitements biopharmaceutiques novateurs pour répondre aux besoins non satisfaits dans les maladies auto-immunes et inflammatoires.

Performance & Momentum

6 Months 26.51 %
1 Year 180.12 %
3 Years 98.62 %
5 Years 99.86 %

Similar stocks to Avalo Therapeutics Inc

Anantys Community

Be the first to share your analysis on Avalo Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases